We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cognitive Behavioral Treatment of Pediatric Trichotillomania

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00043563
First Posted: August 12, 2002
Last Update Posted: December 16, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Institute of Mental Health (NIMH)
Information provided by (Responsible Party):
University of Pennsylvania
  Purpose
This study will compare the effectiveness of cognitive-behavior therapy (CBT) to a minimal attention control (AC) condition for treatment of pediatric trichotillomania (TTM).

Condition Intervention
Trichotillomania Behavioral: Cognitive-Behavior Therapy

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Cognitive Behavioral Treatment of Pediatric Trichotillomania

Further study details as provided by University of Pennsylvania:

Primary Outcome Measures:
  • National Institute of Mental Health (NIMH) Trichotillomania Severity Scale [ Time Frame: 1 week ]
    Semi-structured interview about hair-pulling and related symptoms


Enrollment: 24
Study Start Date: January 2001
Study Completion Date: October 2004
Primary Completion Date: October 2004 (Final data collection date for primary outcome measure)
Detailed Description:

TTM is a persistent impulse control disorder in which the individual acts on urges to pull out his or her own hair. Onset typically occurs by adolescence, and TTM is often associated with significant functional impairment and distress. CBT is a type of psychotherapy designed to change problematic behaviors and thinking. It includes self-monitoring of hair-pulling urges and homework assignments to practice the use of cognitive and behavioral strategies.

Participants are assigned randomly to receive either CBT or AC for 8 weeks. Participants assigned to CBT receive weekly 1-hour sessions of CBT for 8 weeks; participants assigned to AC receive 6 telephone contacts and 2 in-person sessions for 8 weeks. After 8 weeks, CBT participants who respond to treatment enter Phase II, which lasts an additional 8 weeks and includes 4 in-person maintenance sessions. AC participants who are still symptomatic after 8 weeks are offered CBT.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   8 Years to 17 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Primary diagnosis of Trichotillomania
  • Minimum symptom duration of 6 months
  • Presence of a stable parent or guardian

Exclusion Criteria:

  • Other primary psychiatric diagnosis
  • Bipolar illness, pervasive developmental disorder, thought disorder, current major depression, ADD/ADHD
  • Concurrent psychotherapy
  • Currently receiving psychotropic medications
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00043563


Locations
United States, Pennsylvania
Center for the Treatment and Study of Anxiety
Philadelphia, Pennsylvania, United States, 19104
Sponsors and Collaborators
University of Pennsylvania
National Institute of Mental Health (NIMH)
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: University of Pennsylvania
ClinicalTrials.gov Identifier: NCT00043563     History of Changes
Other Study ID Numbers: R21MH061457 ( U.S. NIH Grant/Contract )
DSIR CT-S
First Submitted: August 9, 2002
First Posted: August 12, 2002
Last Update Posted: December 16, 2015
Last Verified: December 2015

Keywords provided by University of Pennsylvania:
Cognitive-behavior Therapy
Minimal Attention Control

Additional relevant MeSH terms:
Trichotillomania
Disruptive, Impulse Control, and Conduct Disorders
Mental Disorders


To Top